NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
Germline mono-allelic loss of the tumour suppressor NF1 predisposes patients to the development of benign lesions but rarely further progression into cancer development. Here the authors use mouse models to show that an NF1 heterozygous microenvironment accelerates the formation of benign tumours bu...
Saved in:
Main Authors: | Jean-Philippe Brosseau, Chung-Ping Liao, Yong Wang, Vijay Ramani, Travis Vandergriff, Michelle Lee, Amisha Patel, Kiyoshi Ariizumi, Lu Q. Le |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/9469062130ae408ba5616d707d78a78d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
by: Julia Neitzel, et al.
Published: (2021) -
LncRNA NR038975, A Serum-Based Biomarker, Promotes Gastric Tumorigenesis by Interacting With NF90/NF45 Complex
by: Sisi Wei, et al.
Published: (2021) -
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
by: Veronica Rendo, et al.
Published: (2020) -
Developmental stability covaries with genome-wide and single-locus heterozygosity in house sparrows.
by: Carl Vangestel, et al.
Published: (2011) -
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
by: Mandar Deepak Muzumdar, et al.
Published: (2016)